KVÅKVÅ3E00X05 — Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00X29 — Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XGC — Introduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E00XKZ — Introduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
KVÅKVÅ3E013GC — Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E013KZ — Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
KVÅKVÅ3E033GC — Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E033GR — Introduction of Other Therapeutic Monoclonal Antibody into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E033KZ — Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach
KVÅKVÅ3E043GR — Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach
KVÅKVÅ3E053GC — Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach
KVÅKVÅ3E053KZ — Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach
